Filing Details
- Accession Number:
- 0001062993-25-011293
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-09 19:13:44
- Reporting Period:
- 2025-06-09
- Filing Date:
- 2025-06-09
- Accepted Time:
- 2025-06-09 19:13:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1860871 | Tevogen Bio Holdings Inc. | TVGN | Biological Products, (No Disgnostic Substances) (2836) | 981597194 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 2011728 | H. Ryan Saadi | C/O Tevogen Bio Holdings Inc. 15 Independence Blvd, Suite 210 Warren NJ 07059 | Chief Executive Officer | Yes | Yes | Yes | No |
Transaction Summary
| Sold: | 1,438,206 shares | Avg. Price: $1.23 | Total Value: $1,768,993.38 |
| Number of Shares After Transactions: | 116,814,453 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-06-09 | 1,438,206 | $1.23 | 116,814,453 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 193,924 | Indirect | By wife |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.10 to $1.425, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
